Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
1.590
+0.020 (1.27%)
At close: Oct 4, 2026
| Market Cap | 5.44B +194.4% |
| Revenue (ttm) | 982.42M +52.4% |
| Net Income | 126.65M +103.0% |
| EPS | 0.15 +34.8% |
| Shares Out | 3.42B |
| PE Ratio | 10.77 |
| Forward PE | 22.71 |
| Dividend | 0.11 (6.71%) |
| Ex-Dividend Date | n/a |
| Volume | 54,801,579 |
| Open | 1.570 |
| Previous Close | 1.570 |
| Day's Range | 1.550 - 1.610 |
| 52-Week Range | 0.808 - 4.110 |
| Beta | 0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 15, 2026 |